ICI Pakistan and AstraZeneca: forging stronger bonds

ICI Pakistan and AstraZeneca have maintained a successful partnership in Pakistan for the past 34 years. ICI’s sustainable business applications, ethical practices, highly skilled team and wide geographical footprint has established AstraZeneca as the number one company in the Cardiology segment and as a leader in the Oncology segment.          

In order to strengthen the partnership and pursue an aggressive growth plan, the AstraZeneca office in Pakistan will now support ICI Pakistan in launching newer, more innovative AstraZeneca brands, and widen the scope of its medical research activities by conducting clinical trials.

 

For more information, please contact
 
ICI Pakistan Limited
Corporate Communications & Public Affairs
Seemi Saad, Manager Corporate Communications & Public Affairs
Dir (021) 2313524, (021) 2318103
Email: seemi.saad@akzonobel.com
 
CMC
Mehreen Rafi, Group Account Manager, Corporate Marketing & Communications Pvt Ltd (CMC)
Tel: (021) 4521639, (021) 4388569, Fax #: 021 4543105,
Email: mehreen@cmc.com.pk